The Cable: AstraZeneca Vaccine and Credit Suisse CEO (Podcast)

Guy Johnson touched on a clinical trial out of the United States showing AstraZeneca's vaccine is 79 percent effective in preventing Covid-19. Lockdowns across Europe intesify and vaccine-roll out lags behind. We hear from Bloomberg Intelligence Senior Pharmaceutical Analyst Sam Fazeli, Bloomberg’s Chad Thomas, Executive VP of AstraZeneca's BioPharmaceuticals Unit, Ruud Dobber, Sharron Bell, Goldman Sachs Global Investment Research Equity Strategist and Credit Suisse CEO Thomas Gottstein.